The properties of temperature-sensitive (ts), insertion or deletion mutants of herpes simplex virus (HSV) were investigated in an in vitro model system for latency. The studies defined virus gene products required for establishment of latency and for reactivation of latent virus. All mutants tested established latency in human foetal lung fibroblasts and could be reactivated by intertypic superinfection with HSV or with human cytomegalovirus. Two mutants of HSV type 1 used in these studies, tsK and in 1411, failed to synthesize active immediate early (IE) polypeptide Vmw175 and were blocked at a very early stage of the virus replication cycle, showing that, at most, only limited gene expression is necessary for the establishment of latency. Mutant dl1403, which lacks the gene encoding IE polypeptide Vmwll0, established latency as efficiently as wild-type HSV. Latent HSV type 2 was reactivated by superinfection with tsK or in1411 but not with dl1403, suggesting that polypeptide Vmw110, which is known to regulate gene expression by trans-activation, is required for reactivation in the in vitro system.
INTRODUCTION
Infection of humans or animals with herpes simplex virus (HSV) is followed by the establishment of latency, in which the viral genome is maintained in neuronal tissues in a noninfectious state (Stevens & Cook, 1971; Baringer & Swoveland, 1973; Cook et al., 1974; Galloway et al., 1979; McLennan & Darby, 1980) . The latent HSV genome exists in a form other than unit length, linear DNA (Rock & Fraser, 1983 Puga et al., 1984; Efstathiou et al., 1986) and is expressed to only a limited extent (Puga et al., 1978; Green et al., 1981 ; Galloway et al., 1982; Stroop et al., 1984; Stevens et al., 1987) . HSV can be reactivated from the latent state by a variety of stimuli, but a common mechanism of induction has not yet been elucidated (Stevens, 1975; Wildy et al., 1982; Harbour et al., 1983 ). An understanding of the molecular processes involved in establishment and maintenance of latency, and in the reactivation of latent virus, will be important for effective control of the clinical symptoms associated with HSV. To advance such studies, in vitro latency systems have been developed in which tissue culture cells harbour non-replicating HSV (O'Neill et al., 1972; O'Neill, 1977; Wigdahl et al., 1981 Wigdahl et al., , 1982a Youssoufian et al., 1982; Nilheden et al., 1985 ; Shiraki & Rapp, 1986) . We recently described an in vitro system which utilizes infection at supraoptimal temperature, 42 °C, to convert HSV type 2 (HSV-2) to a latent state which is stable upon downshift to 37 °C, the normal temperature for virus growth (Russell & Preston, 1986) . Latent virus could be reactivated by superinfection with temperature-sensitive (ts) mutants of HSV type 1 (HSV-I) or with human cytomegalovirus (HCMV).
To define the HSV gene products involved in latency, we have examined the behaviour of ts, insertion (in) and deletion (d/) mutants of HSV in the in vitro latency system. The rationale behind this approach is that mutants which fail to become established in a latent state, or which fail to reactivate latent HSV, must lack functions involved in establishment or reactivation respectively. We have used, in addition to previously described ts mutants, an insertion mutant (in1411) which does not produce the immediate early (IE) polypeptide Vmw175, and a deletion mutant (d/1403) which does not synthesize IE polypeptide Vmw110 (Stow & Stow, 1986) . These two IE polypeptides are important for the transcription of the majority of HSV genes (Preston, 1979; Watson & Clements, 1980; Everett, 1984; O'Hare & Hayward, 1985) , and therefore are of interest for studies of virus gene expression during latency. The availability of tsK, in1411 and d/1403 has provided an opportunity to investigate the roles of Vmw175 and Vmw110 in latency in vitro.
METHODS
Cell cultures. Monolayer cultures of human foetal lung (HFL) cells, supplied by Dr B. Carritt, were grown in Eagle's medium (Gibco) supplemented with 10~ foetal calf serum and containing 0.25~ sodium bicarbonate, 6 mM-glutamine, 100 units each of penicillin and streptomycin per ml, and non-essential amino acids (EF10). For analysis of plaque formation, 2~o human serum was substituted for foetal calf serum (EHu2). Baby hamster kidney (BHK-21 C13) cell monolayers were grown and maintained in Eagle's medium containing 10~ calf serum, 10~ tryptose phosphate broth, and the above concentrations of sodium bicarbonate, glutamine, penicillin and streptomycin (ETC10).
Viruses. HSV-2 strain HG52, HSV-1 strain 17, and ts mutants of HSV-2 (is5) and HSV-1 (tsI and tsK, both syncytial plaque morphology type) were obtained from stocks maintained in the Institute of Virology. HCMV strain AD169 was supplied by Dr K. Fletcher. The HSV-1 deletion mutant dl1403 was constructed and propagated as described by Stow & Stow (1986) , and rescue of the d11403 lesion was performed by transfection of dl1403 DNA with plasmid p JR33, which contains the NcoI plus HpaI fragment specifying the coding and intron sequences of the gene encoding Vmw 1 l0 (Perry et al., 1986; Stow & Stow, 1986) . Progeny from the transfection were screened by hybridization for the presence of two intact copies of the Vmwll0 gene. Four isolates with restriction endonuclease cleavage profiles indistinguishable from wild-type (wt) HSV-1 were selected. The HSV-1 insertion mutant inl411, which has an 8 bp oligonucleotide linker insertion which also creates an in-frame amber termination codon in the Vmwl75 coding sequences, was constructed and propagated as described elsewhere (Russell et al., 1987) .
In vitro latency system. The in vitro latency system described previously (Russell & Preston, 1986 ) was used. Monolayers of HFL cells were infected with wt or mutant HSV at low m.o.i., usually 0.003 p.f.u, per cell (3 x l03 p.f.u, per 35 mm diameter Petri dish), and incubated at 42 °C for 6 days, with a change of growth medium every 2 days. Cultures were then transferred to 37 °C (for wt virus and non-ts mutants) or 31 °C (for ts mutants) and incubated for 4 days at this permissive temperature. Superinfection was carried out at this stage and cultures were incubated at the appropriate temperature. For the determination of reactivation, superinfection was followed by incubation in the presence of EHu2 for 2 days, cultures were stained and plaques were counted. For analysis of DNA, superinfection was followed by incubation in the presence of EF 10 until extensive c.p.e, was evident (2 or 3 days).
Analysis of DNA recovered from latently infected cultures by superinfection. Cell monolayers were washed with icecold phosphate-buffered saline (PBS), scraped into PBS and harvested by centrifugation. Cell pellets were resuspended in lysis buffer (10mM-Tris-HCl, 2mM-MgCI2, 10mM-NaC1, 0.5~ NP40, pH7.5), vortexed vigorously and stored on ice for 5 rain. Lysates were vortexed again, and centrifuged at 6000 g for 2 rain. SDS and EDTA were added to 0.5 % and 10 mM, respectively, and the mixture was extracted twice with phenol/chloroform (1 : 1, v/v) and once with chloroform, NaCI was added to 100 mM and nucleic acids were precipitated by addition of 2.5 vol. ethanol. The cytoplasmic nucleic acids, containing RNA and virion DNA, were then digested with HindIII and ribonuclease A, separated by electrophoresis in a 0.6~ agarose gel, and transferred to GeneScreen plus membrane (New England Nuclear) by the method of Southern (1975) , as modified by Wahl et al. (1979) . The membrane was immersed in 0.4 M-NaOH for 1 rain, rinsed in 0.2 M-Tris-HC1 pH 7.5 containing 2 × SSC (0.3 MNaC1, 0-03 M-sodium citrate) and air-dried for at least 12 h at room temperature. Detection of HSV-2-specific sequences was carried out by hybridization with a plasmid containing the HindIII L fragment of HSV-2 cloned in pAT153, radiolabelled by nick translation (Rigby et al., 1977) to asp. act. of 1 × l0 s to 2 x 108 c.p.m./~tg of DNA. Hybridization, washing of the membrane and autoradiography were carried out as described by Park et al. (1983) .
RESULTS

Establishment of latency in vitro
We previously described an in vitro latency system for HSV-2 in which incubation at a supraoptimal temperature was used to convert HSV to a non-infectious state in HFL cells (Russell & Preston, 1986) . Upon downshift to 37 °C virus was not usually detectable although this is a permissive temperature for HSV replication. HSV-2 could be reactivated by intertypic (11) 95 (26) 31 ( superinfection of the cultures with ts mutants of HSV-I or with HCMV. To investigate the establishment of latency in this system, HFL cells were infected with various ts mutants, the insertion mutant in1411, or the deletion mutant dl1403. Following adsorption of virus, cultures were incubated at 42 °C for 6 days and downshifted to the appropriate permissive temperature for virus growth, 31 °C or 37 °C. Cultures were screened for the presence of infectious virus during the ensuing 4 days, then superinfected with either HCMV at 31 °C or an HSV ts mutant at 38.5 °C. Subsequent appearance of plaques of reactivated virus showed that a particular mutant had been able to establish latency in vitro.
The results of studies on establishment with the HSV-2 mutant ts5 and the HSV-1 mutants tsK and tsI are shown in Table 1 . Ts5 and tsI are both defective in a late function and produce viral DNA and most viral polypeptides at the non-permissive temperature, whereas tsK has a mutation in the coding sequences for the IE polypeptide Vmw175 and produces only the IE polypeptides, plus the early polypeptide Vmw 136, at the non-permissive temperature (Preston, 1979) . Plaques were not observed in any of the infected, 42 °C treated cultures during subsequent incubation at the permissive temperature of 31 °C (results not shown), demonstrating that the replication of these mutants was repressed by incubation at 42 °C, as described previously for wt HSV-2 (Russell & Preston, 1986) . In all cases, however, superinfection with HCMV at 31 °C resulted in the production of plaques, indicating that reactivation of HSV had occurred (Table  1 ). The reactivated virus from ts5-, tsI-and tsK-infected cultures was shown to be parental ts virus rather than revertant virus when cell sonicates were titrated on BHK cells at 31 °C and 38.5 °C (results not shown). Furthermore, virus was not recovered from the latently infected cultures upon HCMV superinfection at the non-permissive temperature (results not shown). These results show that ts mutants, in addition to wt HSV, can establish latency in vitro, and therefore that growth and spread of input virus is not necessary for the interaction to occur.
Further investigation was carried out by use of mutants in1411 and dl1403 (Table 2 ). The phenotype of inl411 is similar to that of tsK (at the non-permissive temperature), since gene expression is limited to the IE polypeptides Vmwl2, Vmw63, Vmw68 and Vmwll0, plus Vmw136. Cultures were infected with in1411 and incubated at 42 °C for 6 days followed by downshift to 37 °C for 4 days. After this period, it was not possible to demonstrate the presence of latent virus by superinfection with HCMV, but this result was probably due to the failure of in1411 to form plaques since Vmw175 is essential for virus growth. Latent in1411 could be reactivated, however, by superinfection with tsI or ts5. In these cases, plaques presumably resulted from reciprocal complementation and, possibly, recombination between in1411 and the superinfecting mutant tsI or ts5. As expected, tsK failed to reactivate in1411 since complementation between these two viruses does not occur. These results confirm that Vmw 175 is not required for establishment or maintenance of latent HSV-2 in vitro.
To establish latency with dl1403 it was necessary to use a tenfold lower input multiplicity than usual, as stocks of this virus have a high number of particles which do not form plaques (Stow & Stow, 1986 ) but cause cell death in vitro. It was found that dl1403 was reactivated efficiently upon superinfection with HCMV, tsK, tsI or ts5 and, surprisingly, that the number of plaques recovered was equivalent to that found in cultures initially infected with a tenfold higher multiplicity of wt HSV-1 (Table 2 ). This was because in d11403 stocks many of the particles which cannot form plaques per se can nevertheless produce plaques when complemented by another non-replicating virus (N. D. Stow & E. C. Stow, unpublished observation). The major point to be made here is that the absence of Vmw110 does not prevent the establishment of latency in vitro.
Reactivation of latent HSV
We have reported previously that HSV-2 is efficiently reactivated from its latent state in vitro by intertypic superinfection with various ts mutants of HSV-1, or by superinfection with HCMV. TsK was able to reactivate HSV-2 at the non-permissive temperature as efficiently as the late mutant tsI, but tsK which had been irradiated with u.v. light to prevent gene expression was unable to induce the formation of plaques of reactivated virus (Russell & Preston, 1986) . Taken together, these results suggested that one or more of the polypeptides synthesized by tsK at the non-permissive temperature is responsible for the reactivation of latent HSV-2. We have used in1411 and dl1403 to investigate further the gene products involved in reactivation. Table 3 shows that in1411 was able to reactivate HSV-2, confirming that IE polypeptide Vmw 175 is not required for reactivation. At an m.o.i, of 0.1 p.f.u, per cell, in 1411 formed a small number of plaques on mock-infected HFL cells due to the presence of revertants which probably arose by recombination with the helper cells used for propagation of in1411 (N. D. Stow & E. C. Stow, unpublished observations). Mutant dl1403 forms plaques on HFL cells, albeit at lower efficiency than on BHK cells (Stow & Stow, 1986) . When this virus was used for reactivation, no increase in plaque number was detected on cells harbouring latent HSV-2 compared with mocktreated cells (Table 3) , and all plaques showed the characteristic morphology produced by dl1403 (Stow & Stow, 1986) , with no evidence for replication of HSV-2. The ability of dl1403 to replicate means that the sensitivity of detection of reactivation is low. Thus, by use of 0.001 p.f.u, of d11403 per cell only 0.1 ~ of the initial HSV-2, or 30 plaques, would be expected, and this would be difficult to detect over a background of 176 plaques (Table 3 ). The value of 30 reactivated plaques represents a minimum estimate since, as shown in Table 2 and discussed above, many particles of dl1403 unable to form plaques alone could be complemented by reactivated HSV-2. On balance, the results shown in Table 3 suggest that d/1403 fails to reactivate latent HSV-2.
To investigate this finding further using a more sensitive technique, reactivation of HSV-2 was analysed by hybridization. Cultures latently infected with HSV-2 were superinfected with Table 3 . dl1403, in1411 or HSV-1 at various m.o.i. Cells were harvested 2 or 3 days later and the presence of HSV-2 DNA in the cytoplasmic fraction was analysed by hybridization, using the cloned HSV-2 HindlII L fragment, derived from Us, as probe. This fragment migrates differently upon electrophoresis from the HSV-1 HindlII fragments B, E, G and N with which it shares homology. Fig. 1 shows that HSV-2 DNA was present in latently infected cultures subsequently superinfected with HSV-1 or in1411 but was not detected in cultures which had been superinfected with dl1403. The presence of cross-hybridizing HSV-1 bands demonstrates that wt HSV-1 and dl1403 replicated efficiently. To ensure that the failure of dt1403 to reactivate HSV-2 was due to the deletion in the gene encoding Vmw110, virus isolates generated by rescue ofdl1403 with a small DNA fragment derived entirely from the Vmw110 gene were tested. Four independently isolated revertants reactivated HSV-2 efficiently (Fig. 2) , showing that the deletion in the gene encoding Vmw110, rather than an alteration in another gene product, is responsible for the failure of dl1403 to reactivate HSV-2.
HSV latency genes Reactivation of latent HSV-2 by HSV-1 mutants*
Although it is clear from the presence of HSV-l-specific fragments that dl1403 replicated in HFL cells infected at less than 1 p.f.u./cell ( Fig. 1 and 2) , it was possible that dl1403 inhibited the replication of HSV-2 when both viruses were present in the same cell. HFL cell cultures were therefore coinfected with 3 p.f.u, of d11403 or rescued virus plus 0.1 p.f.u, of HSV-2 per cell, and virus replication was monitored (Fig. 3) . It was found that HSV-2 replicated in both cases, showing that interference with HSV-2 replication by dl1403 did not account for the failure to reactivate latent virus. As expected from previous studies, dl1403 replicated less efficiently, or more slowly, than rescued virus in HFL cells, and HSV-2 was affected in the same way (Stow & Stow, 1986; Sacks & Schaffer, 1987 ).
DISCUSSION
The experiments described here were aimed at investigating the viral gene products involved in HSV latency. The behaviour of various ts, insertion and deletion mutants was examined in terms of latency establishment and reactivation capabilities in our in vitro latency system. All HSV mutants tested were able to become established in a latent state in vitro, and the most informative results were those obtained using tsK and inl 411, which failed to produce functional Vmw175, synthesized only IE polypeptides plus the 'early' polypeptide Vmw136, and did not replicate viral DNA. The results show that, at most, only the polypeptides produced by tsK and in1411, plus virion components, are involved in establishment of latency. Furthermore, viral DNA synthesis is not a prerequisite for latency, a finding consistent with previous observations that HSV replication does not occur at 42 °C (Crouch & Rapp, 1972; Darai & Munk, 1973; Marcon & Kucera, 1976 : Levine et al., 1980 and that virus can persist in cells after infection in the absence of protein synthesis (Shiraki & Rapp, 1986) . The observation that dl1403 was also On: Thu, 21 Feb 2019 19:39:52 Fig. 2 . DNA from superinfected cultures. Latently infected cultures were established, and DNA was analysed as described in the legend to Fig. 1 . Superinfection was with four independent isolates of virus obtained by rescue ofdl1403 with a cloned DNA fragment, R1 (lanes 1 and 2), R2 (lanes 3 and 4), R3 (lanes 5 and 6), R4 (lanes 7 and 8), or with dll403 (lanes 9 to 12). The multiplicity of superinfection was 0.003 (lanes 1 to 8), 0.03 (lanes 9 and 10) or 0-3 (lanes 11 and 12) p.f.u, per cell. HSV-I (~) and HSV-2 (1~) bands are labelled. Fig. 3 . Co-replication of HSV-2 and dl1403. HFL cells were infected with 3 p.f.u, of dl1403 (lanes 3 to 5) or rescued virus R4 (lanes 6 to 8) plus 0-1 p.f.u, of HSV-2 per cell. Cytoplasmic DNA was extracted after incubation of cultures at 37 °C for 2 h (lanes 3 and 6), 8 h (lanes 4 and 7) or 18 h (lanes 5 and 8), cleaved with HindlII, and hybridized to radiolabelled HSV-2 HindlII L. HSV-2 DNA (lane 1) or HSV-1 DNA (lane 2) were also analysed. HSV-1 (~) and HSV-2 (1~) bands are labelled.
able to become established in a latent state demonstrates that the presence of the IE polypeptide Vmw110 is not an absolute requirement for establishment or maintenance of latency in vitro.
Therefore, little or no viral gene expression is necessary" for the establishment of latency in vitro, and the viral factors involved include not more than the HSV IE polypeptides Vmwl2, Vmw63 and Vmw68, the IE polypeptides Vmw175 or Vmw110, the early polypeptide Vmw136, and possibly components of the input virion.
Previous studies demonstrated that reactivation of latent HSV in vitro by intertypic superinfection is induced by the IE or early functions of H C M V (Colberg-Poley et al., 1981) or HSV (Wigdahl et al., 1982b) . More recent work showed that HSV IE polypeptides, or Vmw136, can reactivate latent HSV in vitro (Russell & Preston, 1986) , and this finding was substantiated by the observation reported here that in1411 can reactivate latent HSV-2. This result shows that the IE polypeptide Vmw175 is not involved in triggering reactivation. Therefore, from these data, at most only the four HSV IE polypeptides Vmwl2, Vmw63, Vmw68 and Vmw110, plus Vmw 136, are required for reactivation induced by HSV superinfection. Virion components are not sufficient, since irradiation with u.v. light destroys the ability of tsK to reactivate HSV-2 (Russell & Preston, 1986) .
The most informative result was obtained using dl1403, which does not produce IE polypeptide Vmw110 but otherwise exhibits a pattern of protein synthesis indistinguishable from that of wt HSV-1 (Stow & Stow, 1986) . Superinfection with dl1403 failed to reactivate latent HSV-2 due to the deletion in the gene encoding Vmwll0, strongly suggesting that Vmw110 is required for reactivation. This polypeptide might act alone or in conjunction with one or more of the virion components and/or the other IE polypeptides, excluding Vmw175. Polypeptide Vmw 110 is capable of stimulating the expression, presumably at the transcriptional level, of a variety of genes introduced into cells by transfection (Everett, 1984; O'Hare & Hayward, 1985; Gelman & Silverstein, 1985; Mavromara-Nazos et al., 1986) . The degree of 'transactivation' can be increased when Vmw175 is present, but to date there are no examples of eukaryotic or animal virus genes which fail to respond to Vmwll0. This polypeptide may therefore be a generalized transactivator like the Epstein-Barr virus BMLF1 gene product or the HCMV IE gene products, which stimulate gene expression in a manner that is not specific to promoter sequences (Everett, 1984; Lieberman et al., 1986; Wong & Levine, 1986 ).
An implication of this reasoning is that transcription of latent HSV DNA (either the entire genome or specific genes) in HFL cells can be activated by Vmw110 but not by the virion transinducing factor which stimulates IE transcription, Vmw65 (Campbell et al., 1984) , nor by Vmw175, both of which are supplied by dl1403. If reactivation by HCMV operates through a similar mechanism, it would be predicted that the IE gene products are the active components.
A recent report shows that latently infected mouse ganglia contain a transcript complementary to Vmw110 mRNA (Stevens et al., 1987) . The mutant dl1403 could not produce this RNA, which might be the product required for reactivation. This possibility seems unlikely, however, since the complementary RNA is implicated in establishment or maintenance of latency rather than reactivation and, from an analysis of reading frames, is unlikely to encode a polypeptide (Perry et al., 1986) .
It is also relevant to note that an IE promoter of simian cytomegalovirus, when integrated into the cellular genome, can be transactivated by tsK in a process which does not require functional ¥mw175 or Vmw65 (Mosca et al., 1987) . These requirements for transactivation are apparentl~y identical to those for reactivation of latent HSV-2 and, although there is no evidence for integration of the latent genome, it is possible that the two events occur by similar mechanisms. It would be interesting to test d11403 in the system described by Mosca et al. (1987) .
Latency in vivo is characterized by episodes of reactivation of HSV, and the in vitro system also exhibits a low background of 'spontaneous' reactivation (Russell & Preston, 1986) . Active Vmw110 presumably is not present before these events occur and is not introduced extrinsically, thus the trigger for spontaneous reactivation must either direct the formation of active Vmw 110 or substitute for its function. The first mechanism could operate by modification of the polypeptide or its transcript, or by stimulation of transcription. Interference with the RNA complementary to the mRNA for Vmw110 (Stevens et al., 1987 ) is also possible. The second mechanism essentially proposes that spontaneous reactivation operates via cellular processes which mimic the effect of generalized transactivators. The observation that latent dl1403 can be reactivated by infection with HCMV, i.e. in a situation where no Vmw110 is present, gives support to the latter hypothesis.
A number of studies have been performed on the behaviour of ts or deletion mutants in the mouse model latency system (McLennan & Darby, 1980; A1-Saadi et aL, 1983; Sears et al., 1985 ; Cook et al., 1986) . In these cases, the establishment of latency depends upon many factors, including the efficiency of virus replication and survival at the site of inoculation, interaction with the host immune system and transport to the ganglion, in addition to any gene expression which may be required. A mutant which fails to establish latency in vivo may be blocked at any of the steps leading to latency, as exemplified by the ts mutant RI-1, which is restricted for growth in neuronal cells (Cook et al., 1986) . One interesting result, however, is that d/1403 can establish latency after injection into the mouse footpad, and can be reactivated upon cocultivation of ganglia (G. B. Clements & N. D. Stow, unpublished results) . This observation is consistent with the hypothesis that reactivation occurs through cellular mechanisms which mimic the transactivating effect of Vmw110.
In conclusion, our results show that no DNA synthesis and little or no viral gene expression is required for the establishment of HSV in a latent state in vitro, suggesting that cellular factors may repress viral gene expression. The IE polypeptide Vmwl 10 is implicated in the reactivation of HSV from its latent state in vitro, emphasizing the importance of understanding the control of HSV gene expression during latency.
